Improving Follow up Care for People After Minor Stroke

Sponsor
Imperial College Healthcare NHS Trust (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05897905
Collaborator
(none)
60
2
14.6

Study Details

Study Description

Brief Summary

The goal of this feasibility study is to ascertain if this follow-up programme of care can feasibly be implemented within a healthcare system with people after minor stroke.

The main feasibility questions are:
  1. To establish recruitment uptake ii) To establish treatment adherence iii) To determine participant retention. Participants will be randomly allocated to the intervention and control group. Those in the intervention group will receive a follow-up telephone call at two weeks after discharge and a second follow-up appointment at six weeks after discharge. Outcome measures will be taken at twelve weeks after discharge.
Condition or Disease Intervention/Treatment Phase
  • Behavioral: Personalised, holistic follow-up appointments underpinned by self determination theory
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
A Feasibility Study Investigating an Early, Personalised, Follow-up Programme for People After Minor Stroke
Anticipated Study Start Date :
Jun 15, 2023
Anticipated Primary Completion Date :
May 31, 2024
Anticipated Study Completion Date :
Aug 31, 2024

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Standard care

All participants will receive a brief routine stroke medical follow-up appointment.

Experimental: Personalised, holistic based follow-up appointments underpinned by self determination theory.

Participants will receive two follow-up appointments at two and six weeks after discharge.

Behavioral: Personalised, holistic follow-up appointments underpinned by self determination theory
Appointment 1 (two weeks after discharge): Address participants knowledge gaps as regards their stroke, medication and secondary prevention. Detailed biopsychosocial review. Understand participant priorities and jointly set goals. Agreeing onward referrals if needed. Written summary sent to GP with copy to participant. Appointment 2 (six weeks): Review priorities identified in post stroke review checklist. Review goals and plans from first appointment. Address any new or persistent information gaps. Review hidden impairments that may be impacting on return to work, activities of daily living, relationships or general well-being. Agreeing onward referrals and action plan. Written summary and plan sent to GP.

Outcome Measures

Primary Outcome Measures

  1. Recruitment rate [Baseline]

    Proportion of participants randomised relative to the total number meeting the inclusion criteria.

  2. Treatment completion rate [6 weeks post randomisation]

    Proportion of participants who attend both follow-up appointments

  3. Retention rate [12 weeks post randomisation]

    Proportion of participants that complete the follow-up questionnaires

Secondary Outcome Measures

  1. PROMIS10 [2 weeks and 12 weeks]

    Patient reported outcome measures information system

  2. Health Care Climate Questionnaire Short Form [Baseline and 12 weeks]

    Patient reported outcome measure

  3. MOCA [Baseline and 12 weeks]

    Cognitive assessment

  4. PHQ9 [12 weeks]

    Mood score

  5. GAD7 [12 weeks]

    Anxiety score

Other Outcome Measures

  1. Qualitative interviews [13 weeks]

    Semi-structured

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult ≥18

  • Clinical or radiological diagnosis of minor stroke from a stroke consultant.

  • Admitted to HASU or seen in rapid assessment/TIA clinic.

  • Pre-admission mRS of 0-3 with no formal package of care prior to stroke.

  • Discharge mRS of 0-3.

  • No onward referral to community therapy team or for package of care.

  • Has capacity to consent.

Exclusion Criteria:
  • Any serious co-morbidities that would impact a person's ability to participate in the follow-up appointments and outcome measurement.

  • Insufficient English to engage in intervention and outcome measures and no family or friends to support with this.

  • Not resident in England.

  • Pregnant women.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Imperial College Healthcare NHS Trust

Investigators

  • Principal Investigator: Jennifer Crow, Imperial College Healthcare NHS Trust

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Imperial College Healthcare NHS Trust
ClinicalTrials.gov Identifier:
NCT05897905
Other Study ID Numbers:
  • 23CX8211
First Posted:
Jun 9, 2023
Last Update Posted:
Jun 9, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Imperial College Healthcare NHS Trust
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 9, 2023